Live Feeds
● LIVE Updated 8d ago · 27 sources tracked

Medicare launches pilot program expanding access to GLP-1 drugs

The Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge on July 1, 2026. This short-term demonstration provides eligible Part D beneficiaries access to specific weight-loss medications for $50 per month. The program runs through December 31, 2027.

RSS Source map (24)

What changed

New details confirm the program's start date, specific monthly costs, and the duration of the demonstration.

Live updates

  1. Medicare GLP-1 Bridge Pilot Launches with $50 Monthly Cost

    The Centers for Medicare & Medicaid Services launched the Medicare GLP-1 Bridge on July 1, 2026. This short-term demonstration provides eligible Part D beneficiaries access to specific weight-loss medications for $50 per month. The program runs through December 31, 2027.

    What's confirmed:

    • The Medicare GLP-1 Bridge is a CMS initiative that started July 1, 2026.
    • Eligible Medicare beneficiaries can obtain certain GLP-1 medications for $50 per month.
    • The program is a short-term demonstration that ends December 31, 2027.
    • The initiative operates outside of the Medicare Part D benefit coverage and payment flow.
    • CMS will use a single central processor for payment to pharmacies, claims adjudication, and prior authorization in 2026.
    • Part D sponsors do not have to opt in for beneficiaries to access these drugs.

    Still unconfirmed:

    • An estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month.
    • The new Medicare GLP-1 program excludes TRICARE For Life beneficiaries.
    confidence 100%

  2. Medicare Launches GLP-1 Bridge Pilot Program

    Medicare is introducing a pilot program to increase access to GLP-1 medications for eligible beneficiaries. The initiative includes the BALANCE Model and a short-term demonstration known as the Medicare GLP-1 Bridge. These programs aim to combine medication access with healthy lifestyle interventions.

    What's confirmed:

    • The Centers for Medicare & Medicaid Services announced the BALANCE Model and the Medicare GLP-1 Bridge short-term demonstration.
    • The BALANCE Model seeks to improve health for Medicare and Medicaid recipients through select GLP-1 medications and lifestyle interventions.
    • Eligible beneficiaries may access GLP-1 prescriptions for weight loss for a fixed $50 monthly copay starting in July.
    • The Medicare GLP-1 Bridge Program will cover Zepbound, Wegovy, and Foundayo.

    Still unconfirmed:

    • Coverage for weight-loss drugs could overwhelm doctors.
    • Millions of people will see their GLP-1 costs plummet.
    confidence 95%